Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Initial Shock Energy for Elective Direct Current Biphasic Electrical Cardioversion of Atrial Fibrillation

NCT07610980 is registered in ClinicalTrials.gov with Motol and Homolka University Hospital as lead sponsor.

NCT NCT07610980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07610980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Initial Shock Energy for Elective Direct Current Biphasic Electrical Cardioversion of Atrial Fibrillation
Lead sponsor
Motol and Homolka University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
May 18, 2026
Completion date
June 30, 2029
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af)